Aditya Birla Sun Life Pharma & Healthcare Fund, Minimum Investment Rs.1,000 NFO closes on July 4, 2019 - MYREALITY.In, Real Estate, Share Market, Mutual Fund, Insurance
Trending
Powered by Blogger.
Saturday, June 22, 2019

Aditya Birla Sun Life Pharma & Healthcare Fund, Minimum Investment Rs.1,000 NFO closes on July 4, 2019



Aditya Birla Sun Life Mutual Fund launches Aditya Birla Sun Life Pharma & Healthcare Fund
An Open Ended equity scheme investing in Pharma and Healthcare Services Sector


Key Highlights

·       NFO opens on June 20, 2019 and closes on July 4, 2019
·       Fund will invest in companies belonging to Indian Pharma, Hospitals, Diagnostics, Wellness & Speciality Chemicals, Contract Research and Manufacturing Services
·       Minimum application amount is Rs. 1,000 for the scheme

Aditya Birla Sun Life Mutual Fund, the mutual fund arm of Aditya Birla Capital Limited, has launched the Aditya Birla Sun Life Pharma & Healthcare Fund, an open ended equity scheme investing in Pharma and Healthcare Services Sector. The fund opens on June 20, 2019.

The Indian Pharma Industry is projected to become US$100bn industry by 2030, with domestic pharma expected to grow at 10-12% per annum. Indian Pharma companies are global leaders in generic drug manufacturing, in fact 1 in every 3 medications sold in the US is supplied by an Indian Pharma Company. The gradual global shift from branded to generic drugs will act as a tailwind and further fuel the exports market for Indian Pharma. Increased Government spending on public healthcare through schemes like ‘Ayushman Bharat’, growing penetration of health insurance, higher life expectancy and increasing spends towards healthcare and wellness will act as a stimulus for growth.


Commenting on the launch, A. Balasubramanian, CEO, Aditya Birla Sun Life AMC Ltd, said “The sector has been a long term outperformer over a 10 year period, except in the past 2-3 year. Poised for a strong rebound, there is opportunity in the coming market cycle to invest, given the attractive valuations and the potential growth in the sector”.
 
Mr. A. Balasubramanian, CEO,
Aditya Birla Sun Life AMC Ltd
With a new business cycle coming into play and new businesses with high growth potential and sticky profit like Diagnostics, Wellness & Specialty Chemicals also available to invest in, this sector is more vibrant than ever before. “To add to novelty, we also have ability to invest in innovators, patent holders & specialty instrument makers in global markets”, added A Balasubramanian.




Apart from the core Pharma and Healthcare space, the fund will also look at other large opportunities in sectors like Hospitals and Diagnostics growing at over 20% CAGR; Wellness businesses growing at 10-12% every year, or the Global Contract Research and Manufacturing Services industry (CRAMS) which is growing at 7% per annum. The scheme can also invest in equities of listed overseas companies, in line with the RBI and SEBI guidelines.

The fund will be managed by Mr. Dhaval Shah. The benchmark index for the fund is S&P BSE Healthcare TRI (Total Return Index).


Data Source: IBEF, Internal Estimate, Evaluate Pharma, pmjay.gov.in, UN World Population Prospects, Mckinsey Global Institute report, National Health Profile 2015, 2018, IRDA Statistical Handbook 2016-17, Edelweiss Research


Mutual Fund investments are subject to market risks, read all scheme related documents carefully.


About Aditya Birla Sun Life Mutual Fund, an Aditya Birla Capital Company

Established in 1994, Aditya Birla Sun Life Mutual Fund (ABSLMF), is co-sponsored by Aditya Birla Capital Limited (ABCL) and Sun Life (India) AMC Investments Inc.

Having total domestic assets under management (AUM) of over Rs. 2464 billion for the quarter ended March 31st, 2019, ABSLMF is one of the leading Fund Houses in India based on domestic average AUM as published by the Association of Mutual Funds of India (AMFI). An impressive mix of reach, a wide range of product offerings across equity, debt, balanced as well as structured asset classes and sound investment performance has helped the company garner around 7 million investor folios as of March 31st, 2019.

With a pan India presence across 270 locations, ABSLMF is committed to deepening mutual fund penetration in the country. The company is ceaselessly working to enhance the appeal of mutual funds across a wider set of investors and advisors across India. Part of this effort includes introducing smart solutions, user-friendly services and conveniences which simplify mutual fund processes with digitization for both – investors as well as distribution partners. ABSLAMF provides sector specific equity schemes, fund of fund schemes, hybrid and monthly income funds, debt and treasury products and offshore funds.

Company Information: Aditya Birla Sun Life AMC Limited (formerly known as Birla Sun Life Asset Management Company Limited, Investment Manager for Aditya Birla Sun Life Mutual Fund) One India Bulls Centre, Tower 1, 17th Floor, Jupiter Mill Compound, 841, S.B. Marg, Elphinstone Road, Mumbai - 400 013. Tel.: 4356 8000. Website: www.adityabirlacapital.com. CIN: U65991MH1994PLC080811

Aditya Birla Capital Limited (ABCL), is the holding company of all the financial services businesses of the Aditya Birla Group. With a strong presence across the life insurance, asset management, private equity, corporate lending, structured finance, project finance, general insurance broking, wealth management, equity, currency and commodity broking, online personal finance management, housing finance, pension fund management and health insurance business, ABCL is committed to serving the end-to-end financial services needs of its retail and corporate customers. Anchored by more than 18,000 employees, ABCL has a nationwide reach and more than 2,00,000 agents / channel partners.

Aditya Birla Capital, through its subsidiaries and joint ventures, manages aggregate assets worth Rs. 3,000 billion and has a lending book of Rs. 630 billion as of March 31st, 2019.

About Sun Life Financial

Sun Life is a leading international financial services organization providing insurance, wealth and asset management solutions to individual and corporate Clients. Sun Life has operations in a number of markets worldwide, including Canada, the United States, the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of March 31, 2019, Sun Life had total assets under management of $1,011 billion. For more information please visit www.sunlife.com

Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF.




Aditya Birla Sun Life Pharma & Healthcare Fund, Minimum Investment Rs.1,000 NFO closes on July 4, 2019 Reviewed by S Chitra on June 22, 2019 Rating: 5 Aditya Birla Sun Life Mutual Fund launches Aditya Birla Sun Life Pharma & Healthcare Fund An Open Ended equity scheme investing in...

No comments: